Skip to content
Movie Casting Call
Author:
XellSmart Biopharmaceutical Co., Ltd.
New Progress — XellSmart Unveiled Phase I Results of Off-the-Shelf Parkinson’s Disease Cell Therapy at MDS & Completed Blinded Phase II Enrollment
October 18, 2026
FDA Grants Fast Track Designation to Xellsmart Off-The-Shelf Cell Therapy for Parkinson’s Disease
August 4, 2026